I still Cry – Ilse Delange

I Still Cry
I’m making flowers out of paper
While darkness takes the afternoon
I know that they won’t last forever
But real ones fade away to soon
I still cry sometimes when I remember you
I still cry sometimes when I hear your name
I said goodbye and I know you’re alright now
But when the leaves start falling down I still cry
It’s just that I recall September
It’s just that I still hear your song
It’s just I can’t seem to remember
Forever more those days are gone
I still cry sometimes when I remember you
I still cry sometimes when I hear your name
I said goodbye and I know you’re alright now
But when the leaves start falling down I still cry
I still cry sometimes when I remember you
I still cry sometimes when I hear your name
I said goodbye and I know you’re alright now
But when the leaves start falling down I still cry
But when the leaves start falling down I still cry
Source: LyricFind

Fair Use Notice: Images/logos/graphics on this page contains some copyrighted material whose use has not been authorized by the copyright owners. We believe that this not-for-profit, educational, and/or criticism or commentary use on the Web constitutes a fair use of the copyrighted material (as provided for in section 107 of the US Copyright Law).

Motto of the Month

Some say ‘seeing is believing’ and sometimes we can’t see with our own eyes what our spiritual mind is seeing.

We don’t need eyes to truly see what matters.

The Eye Sees Only What the Mind Is Prepared To Comprehend

Source:

Henri Bergson? Robertson Davies? Johann Wolfgang von Goethe? Thomas Carlyle? Anais Nin? Anonymous?

Clinical Trials – Computerized Systems

The Food and Drug Administration (FDA) established the Bioresearch Monitoring (BIMO) program of inspections and audits to monitor the conduct and reporting of clinical trials to ensure that data from these clinical trials meet the highest standards of quality and integrity and conform to FDA’s regulations.

Computerized systems used in clinical trials refer to the creation, modification, maintenance, archiving, retrieving or transmitting clinical data intended for submission to the Food and Drug Administration (FDA).

Key Definitions:

Audit Trail: a secure, computer-generated, time-stamped electronic record that allows reconstructions of the data course of events relating to the creation, modification, and deletion of an electronic record.

Certified Copy: it is a copy of the original information that has been verified, as an exact copy having all of the same attributes and information as the original. It must have a dated signature.

Computerized System: it is the computer hardware, software, and associated documents (i.e manuals) that create, modify, maintain, archive, retrieve, or transmit in digital form information related to the conduct of a clinical trial.

Electronic Case Report Form (e-CRF): designed to record information required by the clinical trial protocol to be reported to the sponsor on each trial subject.

Electronic Patient Diary: an electronic record into which a subject participating in a clinical trial directly entrees observations or directly responds to an evaluation checklist or questionnaire

Electronic Record: a combination of text, graphics, data, audio, pictorial, or any other information representation in digital form that is created, modified, maintained, archived, retrieved or distributed by a computer system.

Electronic Signature: a computer data compilation of any symbol or series of symbols, executed, adopted, or authorized by an individual to be legally binding equivalent of the individual’s handwritten signature.

Software Validation: verification and validation is the process of checking that a software system meets specifications and that it fulfills its intended purpose. For these guidelines, the design level validation is that portion of the software validation that takes place in parts of the software life cycle before the software is delivered to the end-user.

Source Documents: original documents and records including, but not limited to, hospital records, clinical and office charts, laboratory notes, memoranda, subjects’ diaries or evaluation checklists, pharmacy dispensing records, recorded data from automated instruments,copies or transcriptions certified after verification as being accurate and complete, microfiches,photographic negatives, microfilm or magnetic media, x-rays, subject files, and records kept at the pharmacy, at the laboratories, and at medico-technical departments involved in the clinical trial.

Principles:

Security measures should be in place to prevent unauthorized access to the data and to the computerized system.

1-Identify at which steps a computerized system will be used to create, modify, maintain, archive, retrieve, or transmit data.

2-Documentation should identify what software and, if known, what hardware is to be used in computerized systems that create, modify, maintain, archive, retrieve, or transmit data. This document should be retained as part of the study records.

3-Source documents should be retained to enable reconstruction and evaluation of the trial.

4-When original observations are entered directly into a computerized system, the electronic record is the source document.

5-The design of a computerized system should ensure that all applicable regulatory requirements for recordkeeping and record retention in clinical trials are met with the same degree of confidence as is provided with paper systems.

6-Clinical investigators should retain either the original or a certified copy of all source documents sent to a sponsor or contract research organization, including query resolution correspondence.

7-Any change to a record required to be maintained should not obscure the original information. The record should clearly indicate that a change was made and clearly provide a means to locate and read the prior information.

8-Change to the data are stored on electronic media will always require an audit trail, in accordance with 21 CRF 11,.10(e). It should include who made the changes, when, and why they were made.

9-The FDA may inspect all records that are intended to support submissions to the Agency, regardless of how they were created or maintained.

10-Data should be retrievable in such a fashion that all information regarding each individual subject in a study is attributable to that subject.

11-Computerized systems should be designed so that all requirements assigned to these systems in a study protocol are satisfied and to preclude errors in data creation, modification, maintenance, archiving, retrieval or transmission.

As we read in this blog about guidance for the industry around computerized systems revolts around data quality and data integrity. The users or people using the data from these systems should have confidence that the data are no less reliable than data in paper form.

In the next blog, we will cover audits and inspections, data entry into this computerized system, security and electronic signatures as a way of certifying the data.

Source:

CFR 11 and ICH

FDA.com